Seeking Alpha

ACADIA Pharmaceuticals (ACAD) moves higher in after-hours trade following the announcement that...

ACADIA Pharmaceuticals (ACAD) moves higher in after-hours trade following the announcement that it will host a conference call and webcast at 8:00 a.m. EST on Tuesday, November 27, to present the top-line results from its Phase III trial of pimavanserin, a treatment for patients with Parkinson's disease psychosis. Shares +6.5% AH.
Comments (1)
  • cmundson
    , contributor
    Comments (2) | Send Message
     
    Good Luck to all...
    27 Nov 2012, 01:50 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector